FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3223011000001102: Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25846501000001116 Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60183301000001118 Respontin 500micrograms/2ml Nebules (GlaxoSmithKline UK Ltd) 20 unit dose 4 x 5 unit dose vials en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Is a Ipratropium bromide 250micrograms/ml nebuliser liquid 2ml unit dose vials 20 unit dose true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Is pack of Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has dispensed dose form Nebuliser liquid false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has dispensed dose form Nebuliser liquid true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has active ingredient Ipratropium bromide false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has manufactured dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has AMP Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has specific active ingredient Ipratropium bromide true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Has dispensed dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Respontin 250micrograms/ml 2ml Nebules (GlaxoSmithKline) 20 unit dose 4 x 5 unit dose vials Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start